STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Bioinformatics and Computational Biology Original Research

Exploring Phytochemicals from Ricinus Communis for Potential Therapeutic Applications in Rheumatoid Arthritis: An in-Silico Approach

  1. Gurusowmyasri Kota Department of Biotechnology, Garden City University, University in Bengaluru

Abstract

Aim: Rheumatoid arthritis (RA) is a long-term autoimmune condition characterized by the immune system mistakenly attacking the joints, leading to swelling, discomfort, and joint deformities. Current management strategies include anti-rheumatic drugs and biologics, which have limitations. This study aims to explore the therapeutic potential of Ricinus communis (castor bean plant) phytochemicals as plant-based therapies for autoimmune conditions, like RA.

Methods: Phytochemicals from Ricinus communis were retrieved using the IMPPAT database, identifying 95 compounds. Their drug-like properties were evaluated using the SwissADME tool, resulting in the selection of seven compounds: Ricinine, Apigenin, Glycolic acid, Shikimic acid, Nicotinamide, threo-9, 10-Dihydroxystearic acid, and uric acid. Toxicity assessments were conducted using the protox tool. Molecular docking was performed with pyrx to evaluate interactions was achieved using BIOVIA.

Results: This study revealed that Ricinus communis Phytochemicals demonstrated strong binding affinities with autoimmune pathway-related proteins 1A8M and 1TNF, indicating significant anti-inflammatory and immunomodulatory potential. These findings suggest their promise as plant-based therapeutic agents for RA.

Conclusion: This research underscores the promising anti-inflammatory and immunomodulatory properties of phytochemicals derived from Ricinus communis. The identified compounds exhibit favorable drug-like and safety profiles, with significant binding to autoimmune pathway-related proteins. These findings provide a foundation for experimental studies and the development of plant-based therapies for autoimmune disorders, such as RA.

Keywords

References (15)

  1. Radu AF, Bungau SG. Management of Rheumatoid Arthritis: An Overview. Cells. 2021;10(11):2857. doi:10.3390/cells10112857
  2. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356-361. doi:10.1038/nature01661
  3. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. European Journal of Radiology. 1998;27:S18-S24. doi:10.1016/s0720-048x(98)00038-2
  4. Bastos LL, Mariano D, Lemos RP, Bialves TS, Oliveira CJF, de Melo-Minardi RC. The Role of Structural Bioinformatics in Understanding Tumor Necrosis Factor α-Interacting Protein Mechanisms in Chronic Inflammatory Diseases: A Review. Immuno. 2024;4(1):14-42. doi:10.3390/immuno4010002
  5. Wu H, Hymowitz SG. Structure and function of tumor necrosis factor (TNF) at the cell surface. In: Handbook of Cell Signaling. Academic Press; 2010. pp. 265–275.
  6. Naji RA, AL-Daher RI, Abood DA, Madlum KN. Immunological Impact of Ricinus communis Leaves Extract on Isolated Human Peripheral Blood Mononuclear Cells. Medical Journal of Babylon. 2023;20(1):120-123. doi:10.4103/mjbl.mjbl_287_22
  7. Jena J, Gupta AK. Ricinus communis Linn: a phytopharmacological review. Int J Pharm Pharm Sci. 2012;4(4):25–29.
  8. Tarachand SP, Thirumoorthy G, Lakshmaiah VV, Nagella P. In silico molecular docking study of Andrographis paniculata phytochemicals against TNF-α as a potent anti-rheumatoid drug. Journal of Biomolecular Structure and Dynamics. 2022;41(7):2687-2697. doi:10.1080/07391102.2022.2037463
  9. Bai LL, Chen H, Zhou P, Yu J. Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking. Frontiers in Pharmacology. 2021;12. doi:10.3389/fphar.2021.690118
  10. Morris GM, Lim-Wilby M. Molecular Docking. Methods in Molecular Biology. 2008:365-382. doi:10.1007/978-1-59745-177-2_19
  11. Agarwal S, Mehrotra RJ. An overview of molecular docking. JSM Chem. 2016;4(2):1024–1028.
  12. Available at https://www.researchgate.net/profile/Shweta-Agarwal-7/publication/303897563_
  13. Mini_Review_An_overview_of_Molecular_Docking/links/575b9fb108aed884620da00a/Mini-Review-An-overview-of-Molecular-Docking.pdf
  14. Gschwend DA, Good AC, Kuntz ID. Molecular docking towards drug discovery. J Mol Recognit. 1996;9(2):175–186. doi:10.1002/(sici)1099-1352(199603)9:23.0.co;2-d.
  15. Elokely KM, Doerksen RJ. Docking Challenge: Protein Sampling and Molecular Docking Performance. Journal of Chemical Information and Modeling. 2013;53(8):1934-1945. doi:10.1021/ci400040d